DE69027123D1 - Proliferative wirkung des leukämie-hemmungsfaktors auf satellitzellen - Google Patents
Proliferative wirkung des leukämie-hemmungsfaktors auf satellitzellenInfo
- Publication number
- DE69027123D1 DE69027123D1 DE69027123T DE69027123T DE69027123D1 DE 69027123 D1 DE69027123 D1 DE 69027123D1 DE 69027123 T DE69027123 T DE 69027123T DE 69027123 T DE69027123 T DE 69027123T DE 69027123 D1 DE69027123 D1 DE 69027123D1
- Authority
- DE
- Germany
- Prior art keywords
- satellite cells
- pct
- cytokines
- lif
- alone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPJ755289 | 1989-11-24 | ||
PCT/AU1990/000556 WO1991007992A1 (en) | 1989-11-24 | 1990-11-20 | Proliferative action of leukaemia inhibitory factor on satellite cells |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69027123D1 true DE69027123D1 (de) | 1996-06-27 |
DE69027123T2 DE69027123T2 (de) | 1997-04-24 |
Family
ID=3774381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69027123T Expired - Fee Related DE69027123T2 (de) | 1989-11-24 | 1990-11-20 | Proliferative wirkung des leukämie-hemmungsfaktors auf satellitzellen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5435999A (de) |
EP (1) | EP0502081B1 (de) |
JP (2) | JP3040815B2 (de) |
AT (1) | ATE138267T1 (de) |
AU (1) | AU624284B2 (de) |
CA (1) | CA2045630A1 (de) |
DE (1) | DE69027123T2 (de) |
HK (1) | HK1003475A1 (de) |
NO (1) | NO922008L (de) |
WO (1) | WO1991007992A1 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571508A (en) * | 1989-12-18 | 1996-11-05 | Amrad Corporation Limited | Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor |
DE69119759T2 (de) * | 1990-03-20 | 1997-01-16 | Amrad Corp Ltd | Verfahren zur steuerung der neuronentwicklung und des neuronunterhalts |
AU3251693A (en) * | 1991-12-24 | 1993-07-28 | Amrad Operations Pty. Limited | A method for the treatment of tumours and sarcomas |
WO1994021272A1 (en) * | 1993-03-17 | 1994-09-29 | Amrad Corporation Limited | A method for treating microbial infection in an animal by administering a composition comprising lif and a cytokine |
US5833978A (en) * | 1995-03-16 | 1998-11-10 | Universite Laval | Method of in vitro preconditioning healthy donor's myoblasts before transplantation thereof in compatible patients suffering of recessive myopathies like muscular dystrophy, for improving transplantation success |
US20020164313A1 (en) * | 1995-03-16 | 2002-11-07 | Tremblay Jacques P. | Compositions comprising preconditioned myoblasts having enhanced fusion properties |
GB2301114A (en) * | 1995-05-24 | 1996-11-27 | Bradley Michael John Stringer | Method for controlling differentiation of precursor cells |
EP0852463B1 (de) * | 1995-06-06 | 2008-09-03 | Case Western Reserve University | Myogene differenzierung menschlicher mesenchymaler stammzellen |
WO1998017784A1 (en) * | 1996-10-18 | 1998-04-30 | Universite Laval | Method for in vitro preconditioning of myoblasts before transplantation |
US20010041342A1 (en) * | 1998-04-01 | 2001-11-15 | The General Hospital Corporation, A Massachusetts Corporation | Molecular marker for muscle stem cells |
US6866842B1 (en) | 1998-05-01 | 2005-03-15 | University Of Pittsburgh | Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction |
US7115417B1 (en) | 1998-05-01 | 2006-10-03 | Chancellor Michael B | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof |
WO2001078754A2 (en) | 2000-04-14 | 2001-10-25 | University Of Pittsburgh | Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
WO2002067867A2 (en) | 2001-02-23 | 2002-09-06 | The University Of Pittsburgh | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
US7115399B2 (en) * | 2001-07-31 | 2006-10-03 | Allergan, Inc. | Pinna reflex assay |
US7627373B2 (en) | 2002-11-30 | 2009-12-01 | Cardiac Pacemakers, Inc. | Method and apparatus for cell and electrical therapy of living tissue |
CN1812800B (zh) | 2003-04-25 | 2013-01-16 | 匹兹堡大学 | 用于促进和增强神经修复和再生的肌肉来源的细胞(mdc) |
US7840263B2 (en) * | 2004-02-27 | 2010-11-23 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression |
US7764995B2 (en) | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
US7828711B2 (en) * | 2004-08-16 | 2010-11-09 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular growth and regeneration using ventricular assist device |
US8060219B2 (en) | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
US7981065B2 (en) | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
GB2433122B (en) * | 2005-12-10 | 2008-07-23 | Endet Ltd | Gas sampling probe |
JP5425641B2 (ja) | 2007-01-11 | 2014-02-26 | ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 尿路病状の処置のための筋由来細胞ならびにその作製および使用の方法 |
WO2010022083A2 (en) | 2008-08-18 | 2010-02-25 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
US9139814B2 (en) * | 2008-09-22 | 2015-09-22 | Universite Laval | Culture medium for myoblasts, precursors thereof and derivatives thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT87133B (pt) * | 1987-04-02 | 1992-07-31 | Amrad Corp Ltd | Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif |
AU609128B2 (en) * | 1987-04-02 | 1991-04-26 | Amrad Operations Pty. Limited | Leukaemia-inhibitory factor |
EP0380646B1 (de) * | 1988-08-04 | 1999-01-20 | Amrad Corporation Limited | (in vitro)-vermehrung von embryonalen stammzellen unter verwendung von leukämie-inhibitionsfaktor (lif) |
WO1990002183A1 (en) * | 1988-08-18 | 1990-03-08 | Genetics Institute, Inc. | Production of a novel lymphokine exhibiting differentiation inhibitory activity |
-
1990
- 1990-11-20 WO PCT/AU1990/000556 patent/WO1991007992A1/en active IP Right Grant
- 1990-11-20 AU AU68967/91A patent/AU624284B2/en not_active Ceased
- 1990-11-20 AT AT91900131T patent/ATE138267T1/de not_active IP Right Cessation
- 1990-11-20 DE DE69027123T patent/DE69027123T2/de not_active Expired - Fee Related
- 1990-11-20 JP JP3500901A patent/JP3040815B2/ja not_active Expired - Fee Related
- 1990-11-20 US US07/741,522 patent/US5435999A/en not_active Expired - Fee Related
- 1990-11-20 EP EP91900131A patent/EP0502081B1/de not_active Expired - Lifetime
- 1990-11-20 CA CA002045630A patent/CA2045630A1/en not_active Abandoned
-
1992
- 1992-05-21 NO NO92922008A patent/NO922008L/no unknown
-
1998
- 1998-03-24 HK HK98102462A patent/HK1003475A1/xx not_active IP Right Cessation
-
1999
- 1999-11-18 JP JP11328151A patent/JP2000128791A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO922008D0 (no) | 1992-05-21 |
NO922008L (no) | 1992-07-20 |
JPH05502224A (ja) | 1993-04-22 |
AU624284B2 (en) | 1992-06-04 |
EP0502081B1 (de) | 1996-05-22 |
AU6896791A (en) | 1991-06-26 |
EP0502081A1 (de) | 1992-09-09 |
US5435999A (en) | 1995-07-25 |
CA2045630A1 (en) | 1991-05-25 |
WO1991007992A1 (en) | 1991-06-13 |
EP0502081A4 (en) | 1993-05-05 |
HK1003475A1 (en) | 1998-10-30 |
JP3040815B2 (ja) | 2000-05-15 |
ATE138267T1 (de) | 1996-06-15 |
JP2000128791A (ja) | 2000-05-09 |
DE69027123T2 (de) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69027123D1 (de) | Proliferative wirkung des leukämie-hemmungsfaktors auf satellitzellen | |
Felix et al. | Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by the osteoblastic cell MC3T3-E1 | |
Vereshchagin et al. | Quaternary mammalian extinctions in northern Eurasia. | |
DE3363781D1 (en) | Homogeneous human-interleukin-2 and process for its preparation | |
DE69527540D1 (de) | Verwendung von stammzellenfaktor und löslichen interleukin-6-rezeptor zur vermehrung der hämatopoietischen vorläuferzellen | |
NZ314644A (en) | Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue | |
EP0453453A4 (en) | Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells | |
GR3022321T3 (en) | Use of il-4 to treat solid tumors | |
AU5283890A (en) | Fibroblast growth factor (fgf)-based stabilized compositions | |
DE69129113T2 (de) | Stimulierung der stroma- und vorläuferzellen im knochenmark | |
US6423681B1 (en) | Method of inducing formation of kidney epithelia from mesenchymal precursors | |
Sauder et al. | Stimulation of muscle protein degradation by murine and human epidermal cytokines: relationship to thermal injury | |
Karagenc et al. | Soluble factors and the emergence of chick primordial germ cells in vitro | |
CA2017315A1 (en) | Interleukin i inhibitor | |
AU4299696A (en) | Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells | |
HU9202026D0 (en) | Method and medical preparative for treatment of thrombocytopenie | |
Braquet et al. | Platelet-activating factor modulates interleukin-6 production by mouse fibroblasts | |
DE3879575D1 (de) | Alpha-carotin zur wachstumshemmung von krebszellen. | |
Austin | Proliferative action of leukaemia inhibitory factor on satellite cells | |
Carmeliet | Interleukin-6 a putative mediator of anterior pituitary hormone secretion during the stress of infection? | |
Chao et al. | Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma. | |
EP0620736A4 (en) | A method for the treatment of tumours and sarcomas. | |
Diezel et al. | The effect of splenopentin (DA SP-5) on in vitro myelopoiesis and on AZT-induced bone marrow toxicity | |
MORIMOTO et al. | Phenotypic alterations of neuropeptide Y, vasoactive intestinal peptide and choline acetyltransferase in rat cultured chromaffin cells as effected by nerve growth factor and glucocorticoid | |
Daniel et al. | Haemopoietic Cells as Targets for Gene Transfer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |